Immortalized Mouse Lymphatic Endothelial Cells-SV40

Cat.No.: CSC-I2192Z

Species: mouse

Morphology: Polygonal

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I2192Z
Description
Immortalized Mouse Lymphatic Endothelial Cells-SV40 have been obtained immortalizing Mouse Lymphatic Endothelial Cells with Lenti-SV40 Lentivirus. Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40 tranduced cells go beyond 20 passges.
Species
mouse
Recommended Medium
SuperCult®Immortalized Mouse Lymphatic Endothelial Cell Medium (Cat No.: CM-I2192Z)
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Morphology
Polygonal
Immortalization Method
SV40 large T antigen
Growth Properties
Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2.
Shipping
Dry Ice.
Quality Control
Real Time PCR was used to quantify SV40T gene expression in immortalized cell line.
free from contaminations (bacteria incl. mycoplasma, fungi, HIV, HAV, HBV, HCV, Parvo-B19) and cross-contaminations
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20°C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized mouse lymphatic endothelial cells (iMLECs), typically generated by stable expression of the SV40 large T antigen, provide a powerful and practical model for studying lymphatic biology. A central advantage of iMLECs is their faithful retention of lineage-defining lymphatic markers. They robustly express the master transcription factor Prox1, the surface glycoprotein podoplanin, the hyaluronan receptor LYVE-1, and the vascular endothelial growth factor receptor VEGFR-3, while lacking the blood endothelial marker von Willebrand factor. Functionally, these cells mount potent proliferative, migratory, and tube-formation responses to VEGF-C, recapitulating key lymphangiogenic steps. They also maintain active acetylated low-density lipoprotein uptake and upregulate adhesion molecules under inflammatory stimuli, demonstrating preserved endothelial cell functions.

Compared with primary LECs, iMLECs offer a homogeneous, genetically stable population that eliminates donor-to-donor variability and drastically reduces animal use. Their unlimited expansion supports long-term studies, high-throughput drug screening, and sophisticated genetic manipulation, including lentiviral transduction and CRISPR/Cas9 editing. Critically, the combination of stable antigenic profiles and consistent functional responsiveness makes them a highly reproducible platform for dissecting lymphangiogenic signaling, evaluating anti-lymphangiogenic therapies, and modeling lymphatic involvement in tumor metastasis and chronic inflammation.

LEC–Cancer Cell Adhesion Induces Reciprocal Changes in Actin Reorganization

Cell adhesion in carcinogenesis is positively and negatively regulated, enabling cancer cells to attach to other cells and the extracellular matrix, favoring their permanence at the cancer stem cells (CSCs) niche or their migration and dissemination to distant sites. The actin cytoskeleton plays a critical role in cell adhesion and migration. Therefore, this study sought to identify the occurrence of changes in actin organization at sites of heterotypic cell–cell interaction between lymphatic endothelial cells (LECs) and the cancer cell lines.

For this purpose, we used the immortalized mouse LEC line and two mouse skin squamous carcinoma cell lines, PDV and HaCa4, both of which express the CSC marker SOX2. In individual cell cultures, LEC cells grew as compact adhesive cell monolayers, displaying a well-defined cortical actin network forming a honeycomb pattern with radial bundles of actin fibers at cell–cell contact sites. On the other hand, epithelial PDV and the epithelioid HaCa4 cells established cell–cell contacts with a polarized actin cytoskeleton organization.

Upon co-culture, we observed distinct morphological changes in both LECs and cancer cells. LEC cells exhibited a more elongated organization and no longer formed a close monolayer. Instead, they organized into an open network, establishing contact with cancer cells. The actin cytoskeleton of LEC and cancer cells appeared reorganized, and areas of directed actin membrane protrusions were evident at heterotypic cell adhesion sites, along with the presence of actin bundles and lamellipodia membrane protrusions. These results underscore the existence of productive adhesive interactions involving the actin cytoskeleton between LECs and cancer cells.

LECs and cancer cells establish heterotypic cell–cell adhesion (Cazzola, Anna, et al., 2023).
Fig. 1. LECs and cancer cells establish heterotypic cell–cell adhesion (Cazzola, Anna, et al., 2023).
LECs and cancer cells exhibit morphology changes and actin reorganization when co–cultured (Cazzola, Anna, et al., 2023).
Fig. 2. LECs and cancer cells exhibit morphology changes and actin reorganization when co–cultured (Cazzola, Anna, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products